However, we have observed residual Akt phosphorylation independent of Src and IGF-1R pathways (Fig. 2C), which likely is explained by other kinases increased during prostate cancer progression, such as c-Met [52] and Axl [53]. The gene discussed is AKT1; the disease is prostate carcinoma.